Unconfigured Ad

Collapse
X
 
  • Time
  • Show
Clear All
new posts
  • mruizm
    Member
    • Apr 2013
    • 22

    #1

    Minimum deep of coverage in a de novo transcriptome analysis

    Hi everyone, i have 4,46 Gigas of information on various sequencing of transcripts in various tissues of Illumina Miseq paired-end reads. I had assembly all these reads and i found that the mean deep of coverage is of 27,9X (Deep of coverage = efficiency of sequencing / efficiency of assembly)
    My question here is, what is de minimun of the deep of coverage for obtain robust information of the assembled transcriptome in a de novo transcriptome analysis?

    Thanks!
    Best regards!
  • Blahah404
    Member
    • Dec 2011
    • 48

    #2
    28X coverage is plenty for assembly of most transcriptomes - I usually digitally normalise coverage down to 20X using khmer.

    Of course it's the extremes that matter - 28X coverage likely means just a few genes account for the majority of the reads, and a large number of reads will have very low or no coverage. If your aim is to quantify the most abundant genes, no problem. If you have some other goal, you may want to consider what your coverage distribution means for your goal.

    Comment

    Latest Articles

    Collapse

    • SEQadmin2
      16S/ITS Profiling vs. Shotgun Metagenomics: What Changes in Your Workflow?
      by SEQadmin2




      NGS has revolutionized clinical microbiology by offering new ways to identify and surveil pathogens without prior knowledge of the target. One popular approach is 16S rRNA and ITS amplicon sequencing, which targets specific microbial markers. But studies are increasingly incorporating shotgun metagenomics, a technique that sequences all DNA from a sample without targeting specific microbial markers. This approach allows more detailed taxonomic classification, detection...
      Today, 06:46 AM
    • SEQadmin2
      Multiomic Liquid Biopsy: What DNA/RNA Panels Reveal That DNA Alone Can’t
      by SEQadmin2



      Tumors contain complex mixtures of cell populations that evolve in response to treatment and host-specific factors. Tissue biopsies provide only static snapshots of a tumor’s state. But what if we could follow that evolution over time using a minimally invasive technique?

      Liquid biopsies can detect tumor-derived material circulating in the bloodstream, providing a way to study treatment response, detect emerging resistance, and discover new biomarkers. Circulating
      ...
      10-14-2026, 09:55 AM

    ad_right_rmr

    Collapse

    News

    Collapse

    Topics Statistics Last Post
    Started by SEQadmin2, 10-28-2026, 09:57 AM
    0 responses
    24 views
    0 reactions
    Last Post SEQadmin2  
    Started by SEQadmin2, 10-28-2026, 09:51 AM
    0 responses
    15 views
    0 reactions
    Last Post SEQadmin2  
    Started by SEQadmin2, 10-22-2026, 11:13 AM
    0 responses
    68 views
    0 reactions
    Last Post SEQadmin2  
    Started by SEQadmin2, 10-22-2026, 10:48 AM
    0 responses
    48 views
    0 reactions
    Last Post SEQadmin2  
    Working...